About Us

In 2017, we have seen the future of bringing innovative, high-quality medicines coming closer. SAANSO is incorporated by ably experienced healthcare professionals having 10+ decades of combined experience in R&D, Manufacturing, and Marketing with the passion of addressing the unmet need for High-Quality Essential Medicines that are Accessible, Affordable & Available (3A to every patient. Saanso is committed to unlocking the potential of chemistry for patients suffering from various illnesses by developing, manufacturing, and delivering innovative therapeutics. Quality by Design (QbD) is our commitment, with cutting-edge science & technologies that hold the potential of significant improvements to health, we are trying to connect the dots of healthcare, connecting pharmaeconomics & global innovative medicine yet making them Accessible, Affordable, and Available. Driven by our passion for what we do, leveraging our experience and well-established network, we, SAANSO through our business associates are addressing the complex challenges in the healthcare industry by connecting the INDIAN MARKET with GLOBAL MEDICINE!

2017

Conceptualised

2019

Laid Foundation Stone to injectable manufacturing plant as per EUGMP standards 

2019

Commencing of Global Operations in LATAM

2022

Expansion of Global operations to CIS, Africa & ASEAN countries  

2022

Launch of Indian operations with Saanso CVS division 

2023

Launch of Saanso Neuroscience (SNS) and Saanso Respiro Science (SRS)

2023

Other Planned Divisions to be launched in FY2023-24 critical care, Oncology, Orthopedics, Gynecology & Pediatrics